Lexeo Therapeutics LXEO
NASDAQ LXEO
$2.94 -0.06 (-1.83%)
As of: Oct 22, 2026 · 3:23 PM EDT

Lexeo Therapeutics (LXEO) EBT Margin (2022)

Updated

Lexeo Therapeutics (LXEO) reported EBT Margin of -9063.76% for FY2022.

Analysis

Lexeo Therapeutics (LXEO) EBT Margin (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,170.23 Bn 1,138.82 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 648.85 Bn 568.71 Bn 17.30 Bn 0.13%
3 AbbVie 504.91 Bn 478.02 Bn 12.70 Bn 25.18%
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn -4.11%
5 Novartis Ag 303.41 Bn 267.40 Bn 11.24 Bn 29.63%
6 Astrazeneca 268.65 Bn 242.33 Bn 12.86 Bn 18.19%
7 Amgen 242.96 Bn 198.36 Bn 7.24 Bn 27.53%
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn -131.41%
9 Pfizer 173.22 Bn 119.87 Bn 10.94 Bn -4.34%
10 Lexeo Therapeutics 252.17 Mn -408.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -3,211.86%
API Access

Lexeo Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=LXEO&period=max&api_key=YOUR_API_KEY